Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses

Autor:	Gauvreau, Gail M., Arm, Jonathan P., Boulet, Louis-Philippe, Leigh, Richard, Cockcroft, Donald W., Davis, Beth E., Mayers, Irvin, FitzGerald, J. Mark, Dahlen, Barbro, Killian, Kieran J., Laviolette, Michel, Carlsten, Christopher, Lazarinis, Nikolaos, Watson, Richard M., Milot, Joanne, Swystun, Veronica, Bowen, Miranda, Hui, Linda, Lantz, Ann-Sofie, Meiser, Karin, Maahs, Suzanne, Lowe, Philip J., Skerjanec, Andrej, Drollmann, Anton, O'Byrne, Paul M.
Zdroj:	In The Journal of Allergy and Clinical Immunology October 2016 138(4):1051-1059
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect